Alopecia areata is an autoimmune condition resulting in hair loss and complete baldness
(alopecia totalis). Published evidence says that it is mediated by T-lymphocytes. Plaquenil
is an anti-inflammatory drug approved by the FDA for malaria, lupus erythematosus, and
rheumatoid arthritis. It has an effect on T-lymphocyte mediated inflammation, making it a
logical choice for a treatment trail for alopecia areata.